Although the exact underlying mechanisms are not yet fully understood, disruptions in NLRP3 inflammasome-related processes have been suggested to play a role in the development of placental inflammation and pre-eclampsia, both of which are observed more frequently in women with GDM than in women with normal glucose tolerance [62]. Here, NLRP3 is linked to gestational diabetes.